🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 6 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/01/2025 | 111,08 | 113,20 | 110,88 | 111,89 | +0,73% | 2,09% | 80.800 |
| 16/01/2025 | 110,69 | 112,26 | 109,02 | 111,08 | +0,73% | 2,93% | 75.200 |
| 15/01/2025 | 110,00 | 111,69 | 107,99 | 110,28 | +1,59% | 3,36% | 135.200 |
| 14/01/2025 | 106,55 | 108,70 | 105,15 | 108,55 | +2,54% | 3,33% | 123.200 |
| 13/01/2025 | 104,71 | 106,20 | 102,79 | 105,86 | -0,40% | 3,26% | 92.400 |
| 10/01/2025 | 108,75 | 109,13 | 104,18 | 106,28 | -3,89% | 4,55% | 86.400 |
| 08/01/2025 | 110,43 | 110,91 | 107,52 | 110,58 | +0,24% | 3,07% | 94.100 |
| 07/01/2025 | 107,70 | 111,65 | 107,70 | 110,31 | +2,21% | 3,67% | 94.600 |
| 06/01/2025 | 110,61 | 112,61 | 107,55 | 107,92 | -2,39% | 4,57% | 72.100 |
| 03/01/2025 | 109,13 | 110,95 | 107,33 | 110,56 | +1,97% | 3,32% | 83.200 |
| 02/01/2025 | 108,12 | 111,40 | 105,90 | 108,42 | +1,19% | 5,09% | 104.400 |
| 31/12/2024 | 106,79 | 109,21 | 105,10 | 107,15 | +1,31% | 3,85% | 110.200 |
| 30/12/2024 | 107,69 | 109,46 | 105,00 | 105,76 | -3,14% | 4,14% | 139.300 |
| 27/12/2024 | 112,83 | 113,14 | 108,19 | 109,19 | -4,43% | 4,39% | 86.400 |
| 26/12/2024 | 113,02 | 114,43 | 112,16 | 114,25 | +0,77% | 2,01% | 144.600 |
| 24/12/2024 | 113,50 | 114,58 | 111,98 | 113,38 | -0,37% | 2,29% | 58.700 |
| 23/12/2024 | 114,59 | 117,54 | 113,00 | 113,80 | -0,73% | 3,96% | 117.800 |
| 20/12/2024 | 112,06 | 115,47 | 111,00 | 114,64 | +0,61% | 3,99% | 551.600 |
| 19/12/2024 | 114,57 | 119,27 | 112,49 | 113,95 | -0,40% | 5,92% | 109.100 |
| 18/12/2024 | 121,26 | 121,31 | 113,33 | 114,41 | -5,00% | 6,58% | 125.900 |
| 17/12/2024 | 122,09 | 123,20 | 116,89 | 120,43 | -1,56% | 5,17% | 131.100 |
| 16/12/2024 | 117,30 | 124,03 | 117,30 | 122,34 | +4,64% | 5,74% | 118.100 |
| 13/12/2024 | 113,70 | 117,28 | 113,59 | 116,91 | +3,00% | 3,25% | 107.200 |
| 12/12/2024 | 120,26 | 120,94 | 113,39 | 113,51 | -5,69% | 6,28% | 106.500 |
| 11/12/2024 | 121,18 | 122,07 | 118,48 | 120,36 | +1,48% | 2,96% | 113.000 |
| 10/12/2024 | 116,81 | 119,77 | 114,00 | 118,60 | +1,94% | 4,94% | 113.500 |
| 09/12/2024 | 124,78 | 125,50 | 114,15 | 116,34 | -6,80% | 9,10% | 156.900 |
| 06/12/2024 | 124,11 | 127,86 | 122,89 | 124,83 | +1,07% | 4,00% | 121.300 |
| 05/12/2024 | 120,08 | 124,24 | 120,08 | 123,51 | +2,09% | 3,46% | 114.800 |
| 04/12/2024 | 120,01 | 123,00 | 119,73 | 120,98 | +0,88% | 2,72% | 73.300 |